|
1
|
Du W and Mei QB: Ubiquitin-proteasome
system, a new anti-tumor target. Acta Pharmacol Sin. 34:187–188.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Campello L, Esteve-Rudd J, Cuenca N and
Martín-Nieto J: The ubiquitin-proteasome system in retinal health
and disease. J Mol Neurobiol. 47:790–810. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang Z, Bi C, Buac D, et al: Organic
cadmium complexes as proteasome inhibitors and apoptosis inducers
in human breast cancer cells. J Inorg Biochem. 123:1–10. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Adams J: The proteasome: a suitable
antineoplastic target. Nat Rev Cancer. 4:349–360. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang H, Chen D, Cui QC, Yuan X and Dou QP:
Celastrol, a triterpene extracted from the chinese ‘Thunder of God
Vine,’ is a potent proteasome inhibitor and suppresses human
prostate cancer growth in nude mice. Cancer Res. 66:4758–4765.
2006.
|
|
6
|
Seemüller E, Lupas A, Stock D, Löwe J,
Huber R and Baumeister W: Proteasome from Thermoplasma
acidophilum: a threonine protease. Science. 268:579–582.
1995.
|
|
7
|
Andreini C, Banci L, Bertini I and Rosato
A: Zinc through the three domains of life. J Proteome Res.
5:3173–3178. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cvek B, Milacic V, Taraba J and Dou QP:
Ni(II), Cu(II), and Zn(II) diethyldithiocarbamate complexes show
various activities against the proteasome in breast cancer cells. J
Med Chem. 51:6256–6258. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Maverakis E, Fung MA, Lynch PJ, Draznin M,
Michael DJ, Ruben B and Fazel N: Acrodermatitis enteropathica and
an overview of zinc metabolism. J Am Acad Dermatol. 56:116–124.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Y, Rodionov DA, Gelfand MS and
Gladyshev VN: Comparative genomic analyses of nickel, cobalt and
vitamin B12 utilization. BMC Genomics. 10:78–103. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Banerjee R and Ragsdale SW: The many faces
of vitamin B12: catalysis by cobalamin-dependent enzymes. Annu Rev
Biochem. 72:209–247. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Casano C, Agnello M, Sirchia R and
Luparello C: Cadmium effects on p38/MAPK isoforms in MDA-MB-231
breast cancer cells. Biometals. 23:83–92. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Abrams MJ and Murrer BA: Metal compounds
in therapy and diagnosis. Science. 261:725–730. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rosenberg B, Vancamp L and Krigas T:
Inhibition of cell division in Escherichia coli by
electrolysis products from a platinum electrode. Nature.
205:698–699. 1965.PubMed/NCBI
|
|
15
|
Wong E and Giandomenico CM: Current status
of platinum-based antitumor drugs. Chem Rev. 99:2451–2466. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Thompson KH and Orvig C: Boon and bane of
metal ions in medicine. Science. 300:936–939. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xiao Y, Bi CF, Fan YH, Cui QC, Zhang X and
Dou QP: L-glutamine Schiff base copper complex as a proteasome
inhibitor and an apoptosis inducer in human cancer cells. Int J
Oncol. 33:1073–1079. 2008.PubMed/NCBI
|
|
18
|
Hartinger CG, Zorbas-Seifried S, Jakupec
MA, Kynast B, Zorbas H and Keppler BK: From bench to
bedside-preclinical and early clinical development of the
anticancer agent indazolium
trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or
FFC14A). J Inorg Biochem. 100:891–904. 2006.PubMed/NCBI
|
|
19
|
Ang WH and Dyson PJ: Classical and
non-classical ruthenium-based anticancer drugs: towards targeted
chemotherapy. Eur J Inorg Chem. 20:4003–4018. 2006.
|
|
20
|
Alderden RA, Hall MD and Hambley TW: The
discovery and development of cisplatin. J Chem Educ. 83:728–734.
2006. View Article : Google Scholar
|
|
21
|
Zhang X, Bi CF, Fan YH, Cui QC, Chen D,
Xiao Y and Dou QP: Induction of tumor cell apoptosis by taurine
Schiff base copper complex is associated the with inhibition of
proteasomal activity. Int J Mol Med. 22:677–682. 2008.PubMed/NCBI
|
|
22
|
Milacic V, Chen D, Giovagnini L, Diez A,
Fregona D and Dou QP: Pyrrolidine dithiocarbamate-zinc(II) and
-copper(II) complexes induce apoptosis in tumor cells by inhibiting
the proteasomal activity. Toxicol Appl Pharmacol. 231:24–33. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zuo J, Bi C, Fan Y, Buac D, Nardon C,
Daniel KG and Dou QP: Cellular and computational studies of
proteasome inhibition and apoptosis induction in human cancer cells
by amino acid Schiff base-copper complexes. J Inorg Biochem.
118:83–93. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tomco D, Schmitt S, Ksebati B, Heeg MJ,
Dou QP and Verani CN: Effects of tethered ligands and of metal
oxidation state on the interactions of cobalt complexes with the
26S proteasome. J Inorg Biochem. 105:1759–1766. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pandeya SN, Smitha S, Jyoti M and Sridhar
SK: Biological activities of isatin and its derivatives. Acta
Pharm. 55:27–46. 2005.PubMed/NCBI
|
|
26
|
Song J, Hou L, Ju C, Zhang J, Ge Y and Yue
W: Isatin inhibits proliferation and induces apoptosis of SH-SY5Y
neuroblastoma cells in vitro and in vivo. Eur J Pharmacol.
702:235–241. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Motaghed M, Al-Hassan FM and Hamid SS:
Thymoquinone regulates gene expression levels in the estrogen
metabolic and interferon pathways in MCF7 breast cancer cells. Int
J Mol Med. 33:8–16. 2014.PubMed/NCBI
|
|
28
|
Daniel KG, Gupta P, Harbach RH, Guida WC
and Dou QP: Organic copper complexes as a new class of proteasome
inhibitors and apoptosis inducers in human cancer cells. Biochem
Pharmacol. 67:1139–1151. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen D, Daniel KG, Chen MS, Kuhn DJ,
Landis-Piwowar KR and Dou QP: Dietary flavonoids as proteasome
inhibitors and apoptosis inducers in human leukemia cells. Biochem
Pharmacol. 69:1421–1432. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Adsule S, Barve V, Chen D, Ahmed F, Dou
QP, Padhye S and Sarkar FH: Novel Schiff base copper complexes of
quinoline-2 carboxaldehyde as proteasome inhibitors in human
prostate cancer cells. J Med Chem. 49:7242–7246. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Padhye S, Yang H, Jamadar A, Cui QC,
Chavan D, Dominiak K, McKinney J, Banerjee S, Dou QP and Sarkar FH:
New difluoro Knoevenagel condensates of curcumin, their Schiff
bases and copper complexes as proteasome inhibitors and apoptosis
inducers in cancer cells. Pharm Res. 26:1874–1880. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Groll M, Ditzel L, Lowe J, Stock D,
Bochtler M, Bartunik HD and Huber R: Structure of 20S proteasome
from yeast at 2.4 Å resolution. Nature. 386:463–471.
1997.PubMed/NCBI
|
|
33
|
Yuko M and Yasuo K: Synthesis of
6-methoxyindoles and indolines. Regioselective C-6 bromination of
indolines and subsequent nucleophilic substitution with a methoxyl
group. J Heterocyclic Chem. 20:349–352. 1983. View Article : Google Scholar
|
|
34
|
Daniel S, Rigobert P and Uli K: Chelated
ester enolates as versatile nucleophiles for direct nucleophilic
attack on aromatic nitro groups. Synlett. 10:1616–1618. 2006.
|
